CNS vs APAM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 04, 2026
CNS
APAM
Investment Advisor Scores
APAM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNS | APAM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 17.9533 | 8.8339 | APAM |
| PEG Ratio | 1.3095 | 1.38 | CNS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.1% | 3.7% | CNS |
| Earnings Growth | 0.0% | 11.8% | APAM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.6/100 | 41.0/100 | CNS |
| Profit Margin | 28.2% | 24.5% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNS
DistributionPrice near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50
APAM
NeutralMixed signals - no dominant trend phase, RSI 58
Fundamentals Snapshot
| Metric | CNS | APAM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 19.6 | 10.8 |
| Trailing P/E | 22.7 | 9.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.5% | 0.5% |
| Operating Margin | 0.3% | 0.4% |
| EPS | 3.25 | 4.28 |
| Dividend Yield | 0.04% | 0.09% |